Electroacupuncture-assisted ribavirin dosing for long COVID: A randomized controlled trial
Peer-Reviewed Publication
Updates every hour. Last Updated: 26-Apr-2025 03:08 ET (26-Apr-2025 07:08 GMT/UTC)
With lawmakers in Washington, D.C. and state houses getting ready to make major health policy decisions, a pair of new University of Michigan studies shows how past policy decisions have affected older Americans with modest or low incomes. The new findings could also help inform upcoming decisions about health insurance programs that are currently open to people with incomes under about $60,000 per person, and programs aimed at those living in or near poverty.
Largest global study since COVID-19 pandemic shows scientists are trusted around the world
A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 in 2021 are less effective in patients with autoimmune diseases. By providing insights into the cellular processes behind that lessened protection, the new study published in Nature Immunology, highlights that lupus patients may require tailored vaccination strategies to enhance protection against COVID-19. The findings could also offer insights into the potential and limits of alternative ways to create immunity to COVID-19 through vaccines.
Diagnosing simultaneous infections of multiple respiratory viruses is challenging. Researchers from Korea have now addressed this issue by developing a TwinDemic Detection (TDD) system, a point-of-care diagnostic tool that leverages a novel, non-enzymatic signal amplification method. By testing its performance using human nasopharyngeal samples, TDD was shown to detect SARS-CoV-2 and influenza A virus simultaneously, highlighting its potential application in rapid on-site testing for a wider range of viruses.